Aim There is not sufficient evidence about whether stool DNA methylation tests allow
prioritizing patients to colonoscopy. Due to the COVID‐19 pandemic, there will be a wait‐list …

A large number of tumor-related methylated genes have been suggested to be of diagnostic
and prognostic values for CRC when analyzed in patients' stool samples; however, reported …

Objective: We performed this meta-analysis to document the diagnostic performance of DNA
hypermethylation in stool for colorectal cancer (CRC). Materials and Methods: Relevant …

Background Prevention and early detection of colorectal cancer (CRC) is a global priority,
with many countries conducting population-based CRC screening programs. Although …

Abstract Background and Aims Stool DNA testing is an emerging and attractive option for
colorectal cancer (CRC) screening. We previously evaluated the feasibility of a stool DNA …

Colorectal cancer (CRC) is fourth most common cancer in men and third in women
worldwide. Developing a diagnostic panel of sensitive and specific biomarkers for the early …

OBJECTIVES: To improve colorectal cancer (CRC) survival and lower incidence rates,
colonoscopy and/or fecal immunochemical test screening are widely implemented. Although …

Objective To summarize the current evidence on the biomarkers associated with DNA
methylation in the screening and diagnosis of colorectal cancer (CRC). Methods A literature …

Aim Many studies have reported detection of aberrant methylation of genes in stool sample
for early colorectal cancer (CRC) or adenomas had high sensitivity and specificity, but still …

Background DNA methylation biomarkers in stool may have applications in early colorectal
cancer (CRC) detection; however, their association with stages of CRC carcinogenesis or …